Net Income (Annual) Chart

View Net Income (Annual) for GERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 -83.50M
December 31, 2024 -174.57M
December 31, 2023 -184.13M
December 31, 2022 -141.90M
December 31, 2021 -116.11M
December 31, 2020 -75.62M
December 31, 2019 -68.55M
December 31, 2018 -27.02M
December 31, 2017 -27.92M
December 31, 2016 -29.54M
December 31, 2015 0.046M
December 31, 2014 -35.67M
December 31, 2013 -38.38M
December 31, 2012 -68.88M
December 31, 2011 -96.85M
Date Value
December 31, 2010 -111.38M
December 31, 2009 -70.37M
December 31, 2008 -62.02M
December 31, 2007 -45.78M
December 31, 2006 -31.36M
December 31, 2005 -33.53M
December 31, 2004 -80.40M
December 31, 2003 -29.88M
December 31, 2002 -33.91M
December 31, 2001 -42.07M
December 31, 2000 -32.57M
December 31, 1999 -46.38M
December 31, 1998 -10.83M
December 31, 1997 -9.641M
December 31, 1996 -10.69M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Precigen, Inc. -250.64M
Editas Medicine, Inc. -160.06M
Agenus, Inc. -3.083M
Amgen, Inc. 7.711B
Anika Therapeutics, Inc. -9.979M